Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.
Santagata S, Napolitano M, D'Alterio C, Desicato S, Maro SD, Marinelli L, Fragale A, Buoncervello M, Persico F, Gabriele L, Novellino E, Longo N, Pignata S, Perdonà S, Scala S.
Santagata S, et al. Among authors: persico f.
Oncotarget. 2017 Aug 19;8(44):77110-77120. doi: 10.18632/oncotarget.20363. eCollection 2017 Sep 29.
Oncotarget. 2017.
PMID: 29100374
Free PMC article.